To evaluate the contribution of GPR37L1 to neuropathic pain, we generated 2 animal models by systemic injection of streptozotoxin (STZ), a diabetes-inducing toxin, and paclitaxel (PTX), a chemotherapy drug. This evidence concerns the gene GPR37L1 and diabetes mellitus.